News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Transition Therapeutics (TTH.TO)'s Alzheimer's Drug Effective in ELND005 Phase II/III Study     10/15/2015
TauRx Completes $135 Million Funding Round to Support Phase III Trials for Key Products     10/8/2015
30-Year-Old Hedge-Fund Whiz Kid’s Axovant (AXON) Starts Alzheimer’s Phase III Trial     10/7/2015
Nestle SA Advances Further into Medicine with Planned Alzheimer's Test     9/23/2015
FORUM Pharma Halts Clinical Trials for Alzheimer’s and Schizophrenia Drug     9/17/2015
Amgen (AMGN) to Help Develop Novartis AG (NVS)'s Alzheimer's and Migraine Drugs     9/3/2015
Eli Lilly (LLY) Cuts Ties With University of California, San Diego (UCSD) on $100 Million Alzheimer’s Program     8/7/2015
Watch Out Gilead (GILD), Investors Feel Vertex (VRTX) May Be Biogen (BIIB)'s Good Fit     8/4/2015
Embattled Vitae Pharma (VTAE) and Boehringer Ingelheim Relationship Takes Another Blow, Drops BACE Inhibitor Program for Alzheimer’s     7/27/2015
As Biogen (BIIB), Eli Lilly (LLY) Fall Short, Roche (RHHBY) Intensifies Work on Two Alzheimer's Drugs     7/23/2015
Biogen (BIIB) and Eli Lilly (LLY)’s Alzheimer’s Drugs Hint At Promise, But Fail To Dazzle     7/23/2015
Investors Excited Over Eli Lilly (LLY) and Biogen (BIIB)'s Upcoming Alzheimer’s Drug Data     7/21/2015
Why All Eyes Will Be on Biogen (BIIB)'s Alzheimer's Data Next Week     7/20/2015
Executive Shuffle and Alzheimer’s Drug Report Creates a Rocky Road for Biogen (BIIB) Stock     7/14/2015
AB Science (AB.PA) Studies Banned in France Due to Side Effects     7/9/2015

News from Around the Web
Aspirin Targets Key Protein In Alzheimer's, Parkinson's, Hungtinton's, Johns Hopkins University Study     12/1/2015
Failing Sense Of Smell Might Be Alzheimer's Warning, Mayo Clinic Study     11/17/2015
Can The Brain’s Immune System Fight Alzheimer’s, University of Rochester Study     11/6/2015
Swedish Diagnostic Method For Alzheimer's Becomes International Standard, University of Gothenburg Study     11/4/2015
Jet Lag-Like Sleep Disruptions Spur Alzheimer’s Memory, Learning Loss, University of California, Irvine Study Finds     10/30/2015
Researchers Close In On A Blood Test For Alzheimer's Disease, Rowan University School of Osteopathic Medicine Study     10/19/2015
Does Fungus Cause Alzheimer's? Scientific Reports Publishes     10/16/2015
A New, Non-Invasive Brain Scan Will Help Us Learn More About How Alzheimer's, Dementia, And Brain Tumors Work, University of Washington Study     10/14/2015
Researcher Optimistic Alzheimer's Can Be Delayed By Five Years     10/7/2015
Women With Alzheimer’s-Related Gene Lose Weight More Sharply After Age 70, SUNY Downstate Medical Center Study     10/6/2015
Cancer Drug Appears To Sharpen Memory Too, Rutgers, The State University Of New Jersey Study     10/6/2015
Computer System Being Developed to Predict Change In The Alzheimer's Brain, MIT Study     10/6/2015
Liquid Crystals Show Potential For Detection Of Neuro-Degenerative Disease, University of Chicago Study     9/25/2015
Increased Activity In Older Brains May Point To New Avenues For Treating Memory Loss, Northwestern University Feinberg School of Medicine Study     9/24/2015
Increased Chances For Early Detection Of Alzheimer’s Disease, Lund University Study     9/23/2015

Press Releases
Anavex (AVXL) Release: Independent Research Describes ANAVEX 3-71 As Potent Cognitive Enhancer In Alzheimer's Disease Models     11/30/2015
Portage Biotech's Biohaven Announces Phase 1 Pharmacokinetic Study Meets Study Objectives And Supports Advancing BHV-0223 And Also Appoints A CEO     11/20/2015
Neuronetrix, Inc. Publishes Peer-Reviewed Paper Validating The Clinical Application Of ERP Biomarkers For Use In Alzheimer's Disease     11/19/2015
Amylyx Announces Support From The ALS Finding A Cure Foundation And The Cure Alzheimer’s Fund To Bring A New Treatment For Amyotrophic Lateral Sclerosis To Clinical Trials     11/17/2015
Cerebain Biotech Presents Corporate Update On Its War Against Alzheimer’s And Dementia     11/17/2015
AVANIR Pharmaceuticals (AVNR) Announces Initiation Of Phase III Trial Of AVP-786 For Agitation In Patients With Alzheimer's Disease     11/16/2015
Concert Pharmaceuticals, Inc. (CNCE) Achieves $2 Million Milestone From AVANIR Pharmaceuticals (AVNR) For Phase III Initiation Of AVP-786 For Agitation In Patients With Alzheimer’s Disease     11/16/2015
PRANA Biotechnology (PRAN) Chief Scientific Advisor Receives Smithsonian American Ingenuity Award     11/16/2015
vTv Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2015     11/13/2015
Transition Therapeutics (TTH.TO) Announces First Quarter Fiscal 2016 Financial Results     11/11/2015
Anavex (AVXL) Confirms Data For Phase 2a Alzheimer’s Trial For ANAVEX 2-73     11/11/2015
Anavex (AVXL) Announces Positive Primary And Secondary Endpoints Were Achieved In A Phase 2a Clinical Trial Of ANAVEX 2-73 In Alzheimer’s Disease?     11/10/2015
NeuroGenetic Pharmaceuticals, Inc. Awarded $2.5 Million Grant From NIA To Conduct Clinical Trials With NGP 555 To Treat And Prevent Alzheimer’s Disease; Reports Initial Results Of Phase Ia Clinical Trial     11/10/2015
Resverlogix (RVX.TO) Presents Important New Data At The Annual American Society of Nephrology Kidney Week Conference     11/9/2015
AgeneBio Presents Pharmacokinetic Profile of Proprietary, Extended-Release, Once-a-Day AGB101 Formulation at 8th Clinical Trials on Alzheimer's Disease     11/6/2015